Literature DB >> 14586796

Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density.

Patrícia Oliveira de Almeida Freire1, Sofia Helena Valente de Lemos-Marini, Andréa Trevas Maciel-Guerra, André Moreno Morcillo, Maria Tereza Matias Baptista, Maricilda Palandi de Mello, Gil Guerra.   

Abstract

Glucocorticoids are essential in the treatment of patients with congenital adrenal hyperplasia (CAH). The opposite actions of glucocorticoids and androgens in bone mass achievement justify a study of bone mineral density (BMD) in these patients. We evaluated BMD in patients with CAH due to classic 21-hydroxylase (CYP21A2) deficiency and investigated the involvement of clinical and laboratory factors in the BMD. This study assessed the clinical and laboratory factors involved in BMD of 45 patients at the Pediatric Unit of Endocrinology, UNICAMP, who had been diagnosed as having classical CAH due to CYP21A2 deficiency including molecular characterization. The sample consisted of 28 females and 17 males; 23 salt-wasting (SW) and 22 simple virilizing (SV) cases, with average of 9.9 years (ranges, 5.1-16.3 years) when bone densitometry was performed. The DEXA method was used for calculating the areal BMD Z score in L2-L4. The variables were analyzed with reference to the BMD for chronological age (BMD/CA), height age (BMD/HA), and bone age (BMD/BA). The mean Z score for BMD/CA was 0.08 +/- 1.21 (-2.55 to 2.64); it was 0.29 +/- 1.33 (-2.01 to 4.00) for BMD/HA, and -0.90 +/- 1.24 (-3.41 to 1.92) for BMD/BA. The BMD/CA was significantly lower in females and in patients on treatment for a long period and of more advanced chronological age. Weight and body mass index (BMI) Z scores showed a positive correlation with advanced BA. The higher the weight and BMI Z scores, the higher the BMD/HA. The BMD/BA values were significantly higher in the group in which BA was closer to CA. The BMD/BA value was significantly lower when compared to the value obtained with height and chronological ages. Sex, duration of treatment, weight, BMI, and bone age have an effect on areal BMD in patients with CAH due to CYP21A2 deficiency, which may be underestimated when evaluated in relation to CA and HA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586796     DOI: 10.1007/s00774-003-0434-6

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  12 in total

1.  Evaluation of impact of steroid replacement treatment on bone health in children with 21-hydroxylase deficiency.

Authors:  M Delvecchio; L Soldano; A Lonero; A Ventura; P Giordano; L Cavallo; M Grano; G Brunetti; M F Faienza
Journal:  Endocrine       Date:  2014-07-01       Impact factor: 3.633

2.  Bone mineral density and body composition in children with congenital adrenal hyperplasia.

Authors:  Alyssa Halper; Belen Sanchez; James S Hodges; Aaron S Kelly; Donald Dengel; Brandon M Nathan; Anna Petryk; Kyriakie Sarafoglou
Journal:  Clin Endocrinol (Oxf)       Date:  2018-03-24       Impact factor: 3.478

Review 3.  Clinical outcomes in the management of congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Marja Thorén
Journal:  Endocrine       Date:  2012-01-07       Impact factor: 3.633

4.  Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency.

Authors:  Anne Bachelot; Zeina Chakhtoura; Dinane Samara-Boustani; Jérome Dulon; Philippe Touraine; Michel Polak
Journal:  Int J Pediatr Endocrinol       Date:  2010-09-28

5.  Bone mineral status in children with congenital adrenal hyperplasia.

Authors:  Amy Fleischman; Julie Ringelheim; Henry A Feldman; Catherine M Gordon
Journal:  J Pediatr Endocrinol Metab       Date:  2007-02       Impact factor: 1.634

Review 6.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

7.  Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative.

Authors:  Richard J Auchus; Selma Feldman Witchel; Kelly R Leight; Javier Aisenberg; Ricardo Azziz; Tânia A Bachega; Linda A Baker; Arlene B Baratz; Laurence S Baskin; Sheri A Berenbaum; David T Breault; Barbara I Cerame; Gerard S Conway; Erica A Eugster; Stephanie Fracassa; John P Gearhart; Mitchell E Geffner; Katharine B Harris; Richard S Hurwitz; Aviva L Katz; Brinda N Kalro; Peter A Lee; Gretchen Alger Lin; Karen J Loechner; Ian Marshall; Deborah P Merke; Claude J Migeon; Walter L Miller; Tamara L Nenadovich; Sharon E Oberfield; Kenneth A Pass; Dix P Poppas; Michele A Lloyd-Puryear; Charmian A Quigley; Felix G Riepe; Richard C Rink; Scott A Rivkees; David E Sandberg; Traci L Schaeffer; Richard N Schlussel; Francis X Schneck; Ellen W Seely; Diane Snyder; Phyllis W Speiser; Bradford L Therrell; Carol Vanryzin; Maria G Vogiatzi; Michael P Wajnrajch; Perrin C White; Alan E Zuckerman
Journal:  Int J Pediatr Endocrinol       Date:  2011-01-10

Review 8.  Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiency.

Authors:  Annamaria Ventura; Giacomina Brunetti; Silvia Colucci; Angela Oranger; Filomena Ladisa; Luciano Cavallo; Maria Grano; Maria Felicia Faienza
Journal:  Biomed Res Int       Date:  2013-01-08       Impact factor: 3.411

9.  Bone mineral density in children and adolescents with congenital adrenal hyperplasia.

Authors:  Paulo Alonso Garcia Alves Junior; Daniel Luis Gilban Schueftan; Laura Maria Carvalho de Mendonça; Maria Lucia Fleiuss Farias; Izabel Calland Ricarte Beserra
Journal:  Int J Endocrinol       Date:  2014-03-06       Impact factor: 3.257

10.  Bone mineral status in Egyptian children with classic congenital adrenal hyperplasia. A single-center study from Upper Egypt.

Authors:  Kotb Abbass Metwalley; Abdel-Rahman Abbdel-Hamed El-Saied
Journal:  Indian J Endocrinol Metab       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.